| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CW | Common Stock | Options Exercise | $0 | +7,113 | +18% | $0.000000 | 46,018 | 17 Mar 2025 | Direct | F1, F2 |
| transaction | CW | Common Stock | Sale | $1,018,859 | -3,131 | -6.8% | $325.41 | 42,887 | 18 Mar 2025 | Direct | F3, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CW | Restricted Stock Unit | Options Exercise | $0 | -7,113 | -27% | $0.000000 | 19,508 | 17 Mar 2025 | Common Stock | 7,113 | Direct | F1, F2, F5 |
| Id | Content |
|---|---|
| F1 | These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 17, 2022. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant. |
| F2 | No price on the date of issue. The restricted stock units were granted as an employee benefit transaction. |
| F3 | Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines. |
| F4 | The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $323.24 to $327.65, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price. |
| F5 | Share total includes dividend credits earned on prior outstanding grants. |